Cargando…
Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
AIM: To study impact of baseline mental health disease on hepatitis C virus (HCV) treatment; and Beck’s Depression Inventory (BDI) changes with sofosbuvir- and interferon-based therapy. METHODS: This is a retrospective cohort study of participants from 5 studies enrolled from single center trials co...
Autores principales: | Tang, Lydia Shuk Yee, Masur, Jack, Sims, Zayani, Nelson, Amy, Osinusi, Anu, Kohli, Anita, Kattakuzhy, Sarah, Polis, Michael, Kottilil, Shyam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099584/ https://www.ncbi.nlm.nih.gov/pubmed/27872683 http://dx.doi.org/10.4254/wjh.v8.i31.1318 |
Ejemplares similares
-
Sustained Virologic Response for Chronic Hepatitis C Infection After 27 Days of Treatment with Sofosbuvir and Ribavirin
por: Meissner, Eric G., et al.
Publicado: (2014) -
Hepatitis C eradication with sofosbuvir leads to significant metabolic changes
por: Morales, Amilcar L, et al.
Publicado: (2016) -
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study
por: Petersen, Tess, et al.
Publicado: (2015) -
Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1
por: Ozono, Yoshinori, et al.
Publicado: (2017) -
Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
por: Hahn, Katherine J., et al.
Publicado: (2015)